| Value | ₹0.23 Cr |
|---|
BSE filing, NSE: RADHEY. Summary written from the filing by ALFA Finder's alert engine.
Le Lavoir Ltd: key numbers
- Share price
- ₹44.80
- Market cap
- ₹15.54 Cr
- Revenue (annual)
- ₹6.64 Cr
- Net profit (annual)
- ₹2.24 Cr
- P/E (TTM)
- 7.5×Sector 50.0×
- Promoter holding
- 3.51%+0.00% QoQ
- FII holding
- 0.95%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Le Lavoir Ltd
All →Le Lavoir Board Meeting Date
Le Lavoir will hold a board meeting on 4 November 2026 to consider unaudited quarterly results. The trading window stays closed until 6 November 2026.
Le Lavoir Other Announcement
LE Lavoir Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, pursuant to SEBI Regulation 31(1)(b).
Le Lavoir Other Announcement
Le Lavoir Limited submitted the confirmation certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th September, 2026.
Le Lavoir Annual General Meeting
Le Lavoir Limited submitted the Scrutinizer's Report for its 45th Annual General Meeting held on September 29, 2026, detailing voting results on company resolutions.
Le Lavoir Management Change
Two Independent Directors, Mr. Amit Kumar Bera and Mr. Samrat Mondal, ceased to hold office after shareholders rejected their reappointment resolutions at the 45th AGM.
Le Lavoir Capacity Expansion
Le Lavoir Limited leased premises in Bengaluru to establish a new laundry processing, office, and warehousing facility, expanding its operational footprint in the region.
- facility area
- 2400.0 sq. ft.
Other fund raise announcements
All →Sudarshan Pharma Industries Fund Raise of ₹72 Cr
Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.
- Value
- ₹72.00 Cr
Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr
Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.
- Value
- ₹68.20 Cr
Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.
Gujarat Inject (Kerala) Fund Raise of ₹3 Cr
Gujarat Inject Kerala's board approved a Rs.3 Crore preferential warrant issue to public investors. Authorised capital will rise to Rs.17.63 Crore, subject to shareholder approval.
- Value
- ₹3.00 Cr